Skip to content
★ Sign in to follow
안국

안국약품 Stock: price and insider trades · South Korea

KR·Mcap ₩107.4BHealth Care

안국약품: what insiders have been doing

This page follows insider dealings at 안국약품 as filed with DART (FSS), a company from the Health Care sector. 2 insiders have disclosed 7 filings since 2 November 2025.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

With 7 filings in twelve months, the company is in line with the median of 7 filings across the 2,655 companies we follow on the same exchange. Since 2021, the database holds no purchases and 2 sales by insiders of the company.

There has been no open-market purchase by an insider of 안국약품 for at least a year. Typically, a trade is published a median of 1 day after it takes place. The shorter that gap, the sooner other investors can see what insiders have done.

In the same sector, recent insider purchases at Dynavox Group AB and UCB also feature in our signals. Source: insider filings from DART (FSS). Past trades are no guide to future returns.

Insider Decl.
18
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€474,012
2 ops. · all time

Who traded when

BuySale
어진1 sale
Fundamental score
Ranked 5,776 of 26,911 companies
66.1
score / 100
Value
77
Quality
56
FCF yld35%
Earn yld7.0%
EV/EBITDA9.3x
ROE13%
Gross mgn65%
Net mgn2.4%
Debt/EBITDA3.8x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

₩9,450
Analyst consensus
·
Income statement
Revenue₩306.9B
Gross profit₩200.3B65% margin
EBITDA₩19.2B6% margin
Net income₩7.5B6.3% margin
Valuation
Beta0.76
Balance sheet & cash
Market cap₩107.4B
Total debt₩73.1B
Free Cash Flow₩37B
Debt / Equity43%
Profitability & ownership
ROE12.6%
ROA4.7%
% insiders48.2%
% institutions0.2%
Last declaration on 30 June 2026
Declarations20 total
  • Other
    Other(filed)
    0DART
  • Other
    Other(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    0DART
    0KRXDART:20260417000582
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    0DART
    0KRXDART:20260227007740
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    0DART
    0KRXDART:20251212000350
  • ▼
    대량보유자Executives
    €154kest.0DART
    30,000 sharesKRXDART:20250605000335
  • ▼
    Executives
    €320kest.0DART
    70,000 sharesKRXDART:20241105000164
  • ●
    Executives
    0DART
    0KRXDART:20240702000346
  • ●
    Executives
    0DART
    0KRXDART:20240605000492
  • ●
    Executives
    0DART
    0KRXDART:20231115000324
  • ●
    Executives
    0DART
    0KRXDART:20230704000415
  • ●
    Executives(filed)
    0DART
    0KRXDART:20221226000287
  • ●
    Executives(filed)
    0DART
    0KRXDART:20220704000320
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives
    Executives(filed)
    0DART
  • ●
    Executives(filed)
    0DART
    0KRXDART:20210513000938

20 of 20 declarations

About 안국약품

안국약품 is a South Korean company specializing in the manufacture of pharmaceutical products. It is listed on the XKRX market.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations